Head-to-head studies of botulinum toxin A in aesthetic medicine: Which evidence is good enough?

Journal of the American Academy of Dermatology

Volumn 56, Issue 6, 2007, Pages 1066-1067

  Rzany, Berthold ^a   Nast, Alexander ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

CLINICAL PRACTICE; CLINICAL TRIAL; DOSE RESPONSE; ESTHETICS; HUMAN; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; WRINKLE;

BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, INTRAMUSCULAR; NEUROMUSCULAR AGENTS; RANDOMIZED CONTROLLED TRIALS; RECONSTRUCTIVE SURGICAL PROCEDURES; RESEARCH DESIGN; SKIN AGING; TREATMENT OUTCOME;

EID: 34248231751     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.12.038     Document Type: Letter

References (8)

1. Lowe P., Patnaik R., and Lowe N. Comparison of two formulations of botulinum toxin type A for the treatment of glabellar lines: a double-blind, randomized study. J Am Acad Dermatol 55 (2006) 976-982
2. Lowe P., Patnaik R., and Lowe N.J. A comparison of two botulinum type a toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study. Dermatol Surg 31 (2005) 1651-1654
3. Carruthers J.A., Lowe N.J., Menter M.A., Gibson J., Nordquist M., Mordaunt J., et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 46 (2002) 840-849
4. Carruthers J.D., Lowe N.J., Menter M.A., Gibson J., and Eadie N. Double-blind, placebo-controlled study of the safety and efficacy of botulinum toxin type A for patients with glabellar lines. Plast Reconstr Surg 112 (2003) 1089-1098
5. Monheit G., Carruthers A., Brandt F., and Rand R. A randomized, double-blind, placebo-controlled study of Reloxin™ (Dysport®, botulinum toxin type-A) for the treatment of glabellar lines: determination of optimal dose. Dermatol Surg 33 Suppl 1 (2007) S51-S59
6. Ascher B., Zakine B., Kestemont P., Baspeyras M., Bougara A., and Santini J. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines. J Am Acad Dermatol 51 (2004) 223-233
7. Rzany B., Ascher B., Fratila A., Monheit G.D., Talarico S., and Sterry W. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. Arch Dermatol 142 (2006) 320-326
8. Honeck P., Weiss C., Sterry W., and Rzany B. Reproducibility of a four-point clinical severity score for glabellar frown lines. Br J Dermatol 149 (2003) 306-310